Merck (MRK) Tops Q1 EPS by 6c; Lowers FY13 EPS Outlook; Boosts Buyback
Tweet Send to a Friend
Merck & Co., Inc. (NYSE: MRK) reported Q1 EPS of $0.85, $0.06 better than the analyst estimate of $0.79. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
